Adaptive Biotechnologies Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Adaptive Biotechnologies Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q3 2024.
  • Adaptive Biotechnologies Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 148M shares, a 1.94% increase year-over-year.
  • Adaptive Biotechnologies Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 144M shares, a 1.31% increase from 2022.
  • Adaptive Biotechnologies Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 143M shares, a 1.54% increase from 2021.
  • Adaptive Biotechnologies Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 140M shares, a 6.96% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 148M +2.81M +1.94% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 147M +3.02M +2.09% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 146M +2.28M +1.59% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 144M +1.87M +1.31% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 145M +1.78M +1.24% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 144M +2.03M +1.43% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 144M +1.81M +1.28% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 143M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 143M +2.1M +1.49% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 142M +2M +1.43% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 142M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q3 2021 141M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 140M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.